Related Experiment Video
Updated: May 24, 2026

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
The coagulopathy in sepsis: significance and implications for treatment
Paola Saracco1, Pasquale Vitale, Carlo Scolfaro
1Hematology Unit, Department of Pediatrics, University of Turin;
Insights
Sepsis-associated coagulopathy, including disseminated intravascular coagulation (DIC), impairs microvascular function and predicts outcomes. Strategies targeting coagulation activation or restoring anticoagulation show promise but require further clinical trials.
Area of Science:
- Coagulation and Thrombosis
- Critical Care Medicine
- Sepsis Pathophysiology
Background:
- Sepsis-induced coagulopathy spans mild alterations to severe disseminated intravascular coagulation (DIC).
- DIC contributes to microvascular dysfunction and organ failure in sepsis.
- Coagulation activation consumes platelets and factors, potentially causing bleeding.
Purpose of the Study:
- To review the role of coagulopathy in sepsis pathogenesis and outcomes.
- To discuss novel supportive strategies for sepsis-related coagulopathy.
- To highlight the need for further clinical trials on these strategies.
Main Methods:
- Literature review of sepsis-associated coagulopathy.
- Analysis of coagulation pathways involved in sepsis.
- Discussion of emerging therapeutic interventions.
Main Results:
- Sepsis-related coagulopathy is an independent predictor of clinical outcome.
- Enhanced intravascular fibrin deposition results from complex coagulation dysregulation.
- Potential strategies include inhibiting tissue factor or restoring anticoagulant pathways.
Conclusions:
- Current evidence suggests DIC is integral to sepsis-induced organ failure.
- Restoring physiological anticoagulation (e.g., recombinant human activated protein C) warrants investigation.
- Further clinical trials are essential to establish the efficacy of novel treatments in pediatric and adult sepsis.
Abstract:
Sepsis related coagulopathy ranges from mild laboratory alterations up to severe disseminated intravascular coagulation (DIC). There is evidence that DIC is involved in the pathogenesis of microvascular dysfunction contributing to organ failure. Additionally, the systemic activation of coagulation, by consuming platelets and coagulation factors, may cause bleeding. Thrombin generation via the tissue factor/factor VIIa route, contemporary depression of antithrombin and protein C anticoagulant systems, as well as impaired fibrin degradation, due to high circulating levels of PAI-1, contribute to enhanced intravascular fibrin deposition. This deranged coagulopathy is an independent predictor of clinical outcome in patients with severe sepsis. Innovative supportive strategies aiming at the inhibition of coagulation activation should comprise inhibition of tissue factor-mediated activation or restoration of physiological anticoagulant pathways, as the administration of recombinant human activated protein C or concentrate. In spite of some promising initial studies, additional trials are needed to define their clinical effectiveness in adults and children with severe sepsis.
More Related Videos
Related Concept Videos
Acute Inflammation III: Local and Systemic Effects
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation
Venous Thrombosis III: Interprofessional Care
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
